We are live on ! Find out more
PCRX icon

Pacira BioSciences
PCRX

205 hedge funds and large institutions have $3.58B invested in Pacira BioSciences in 2015 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 75 increasing their positions, 71 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 36

3% more funds holding

Funds holding: 200 → 205 (+5)

6% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 71

3% more capital invested

Capital invested by funds: $3.48B → $3.58B (+$102M)

0% more call options, than puts

Call options by funds: $27.4M | Put options by funds: $27.4M

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
205
Holders Change
+5
Holders Change %
+2.5%
% of All Funds
5.46%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
41
Increased
75
Reduced
71
Closed
36
Calls
$27.4M
Puts
$27.4M
Net Calls
+$19K
Net Calls Change
-$7.62M

Top Buyers

Rank Fund Capital Flow
1
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$73.9M
2
JHIU
Janus Henderson Investors US
Colorado
+$57.4M
3
MCM
Marsico Capital Management
Colorado
+$27.4M
4
SI
Standard Investments
New York
+$27.1M
5
PC
PointState Capital
New York
+$23.3M

Top Sellers

Rank Fund Capital Flow
1
NCGI
Next Century Growth Investors
Minnesota
-$30.8M
2
Bank of New York Mellon
Bank of New York Mellon
New York
-$21.8M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$18.5M
4
CCI
Columbus Circle Investors
-$16.7M
5
GGHC
Gilder Gagnon Howe & Co
New York
-$14.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
DIA
76
Denver Investment Advisors
Colorado
$4.16M +$173K +1,710 +4%
Dimensional Fund Advisors
77
Dimensional Fund Advisors
Texas
$4.16M -$332K -3,270 -7%
RFC
78
Russell Frank Company
Washington
$3.93M -$4.94M -48,647 -52%
KBC Group
79
KBC Group
Belgium
$3.76M +$1.44M +14,159 +50%
D.E. Shaw & Co
80
D.E. Shaw & Co
New York
$3.75M +$2.95M +29,076 +222%
GC
81
Guggenheim Capital
Illinois
$3.74M +$877K +8,642 +26%
PAM
82
Paradigm Asset Management
New York
$3.59M +$497K +4,900 +14%
AC
83
Ascend Capital
California
$3.55M +$4.06M +40,000 New
RhumbLine Advisers
84
RhumbLine Advisers
Massachusetts
$3.54M +$643K +6,340 +19%
Swiss National Bank
85
Swiss National Bank
Switzerland
$3.4M +$50.7K +500 +1%
ProShare Advisors
86
ProShare Advisors
Maryland
$3.37M +$465K +4,583 +14%
NFA
87
Nationwide Fund Advisors
Ohio
$3.2M -$1.14M -11,202 -24%
ARTA
88
A.R.T. Advisors
New York
$3.17M -$2.44M -24,068 -40%
CPS
89
Counsel Portfolio Services
Ontario, Canada
$3.12M +$61.9K +610 +2%
OPPM
90
Opus Point Partners Management
New York
$3.1M +$3.55M +34,949 New
Citadel Advisors
91
Citadel Advisors
Florida
$2.98M +$3.41M +33,578 New
Citigroup
92
Citigroup
New York
$2.82M +$1.13M +11,091 +54%
GH
93
GAM Holding
Switzerland
$2.73M +$1.09M +10,700 +54%
CS
94
Credit Suisse
Switzerland
$2.66M -$1.97M -19,459 -39%
AIG
95
American International Group
New York
$2.51M +$98.2K +968 +4%
State Board of Administration of Florida Retirement System
96
State Board of Administration of Florida Retirement System
Florida
$2.44M -$167K -1,646 -6%
MLICM
97
Metropolitan Life Insurance Company (MetLife)
New York
$2.43M -$4.06K -40 -0.1%
GCP
98
GSA Capital Partners
United Kingdom
$2.42M +$1.8M +17,700 +185%
Susquehanna International Group
99
Susquehanna International Group
Pennsylvania
$2.19M -$628K -6,186 -20%
MOACM
100
Mutual of America Capital Management
New York
$2.14M -$70K -690 -3%
2 3
4
5 6

PCRX Hedge Fund Activity: Q1 2015 in Review

205 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q1 2015, worth a combined $3.58B — up 2.9% from $3.48B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new PCRX positions and 36 closed out — a net gain of 5 holders — while 75 added to existing stakes and 71 trimmed.

The largest buyer was Westfield Capital Management, opening a new position worth an estimated $73.9M. The largest seller was Next Century Growth Investors, cutting an estimated $30.8M.

  • 205 institutional investors held Pacira BioSciences (PCRX) as of Q1 2015, up from 200 in Q4 2014.
  • Funds reported $3.58B of Pacira BioSciences stock for Q1 2015, up 2.9% quarter-over-quarter.
  • 41 funds opened new Pacira BioSciences positions in Q1 2015 and 36 closed out, a net change of +5 holders.
  • The largest Pacira BioSciences buyer in Q1 2015 was Westfield Capital Management, an estimated $73.9M added.
  • The largest Pacira BioSciences seller in Q1 2015 was Next Century Growth Investors, an estimated $30.8M sold.

Based on aggregated 13F filings for Q1 2015.